Non-viral gene therapy delays onset of eye disease
In one of only two studies of its kind, a study from researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts demonstrates that non-viral gene therapy can delay the onset of some forms of eye disease and preserve vision.
The eye disease age-related macular degeneration has declined in the last 15 years, US researchers say.